EP70: Building Single-Cell Atlases to Profile Nectin-4 for Antibody-Drug Conjugate (ADC) Development

Antibody-drug conjugates (ADCs) are transforming oncology—unlocking precise, targeted delivery of cytotoxic therapies while minimizing off-target effects. But success hinges on one critical factor: identifying highly selective tumor-associated antigens. Join us to explore how custom single-cell atlases can accelerate ADC development by enabling robust target validation across both disease and healthy tissues. In this session, we’ll cover: • Building disease- and healthy-tissue atlases using curated public single-cell datasets • Exporting atlases to BBrowserX Pro for downstream analysis • Comparing Nectin-4 expression across cancer subtypes and normal tissues 🗓️ Friday, March 27, 2026 ⏰ 9 AM CET | 3 PM ICT | 5 PM JST 🔗 Register here: bioturing.com/SCSE_signup_eu_asia #SingleCell #SingleCellDatabase #ADC #DrugDiscovery #Bioinformatics #Oncology